Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gram-positive bacterial cell envelope is a complex, multi-layered structure essential for the survival, structural integrity, and pathogenesis of Gram-positive bacteria. It is primarily characterized by a thick layer of peptidoglycan (murein) interspersed with teichoic acids, all of which reside outside a single cytoplasmic membrane (Silhavy et al., 2010, Cold Spring Harb Perspect Biol). Associated macromolecular synthesis refers to the coordinated biochemical pathways—such as the Lipid II cycle and the action of penicillin-binding proteins (PBPs)—that construct and maintain these components (Sarkar et al., 2021, Molecules). This system is a primary therapeutic target because its components are unique to bacteria, providing high selective toxicity for treating infections caused by pathogens like Staphylococcus aureus and Streptococcus pneumoniae. Antibiotics targeting this system, including beta-lactams and glycopeptides, work by disrupting cell wall assembly or membrane stability, leading to osmotic lysis and bacterial death (StatPearls, 2023, Antibiotics). However, this entry is classified as incorrect for a single molecular target because it represents a broad biological system and a collection of diverse enzymes and structural components rather than a single protein or receptor.
Inhibition of peptidoglycan cross-linking (transpeptidation) via penicillin-binding proteins, inhibition of cell wall precursor transport (Lipid II cycle), disruption of cytoplasmic membrane integrity and potential, and inhibition of early-stage murein monomer synthesis.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gram-positive bacterial cell envelope and associated macromolecular synthesis.